Stryker beat estimates on Thursday, reporting a net income of $57 million in its third quarter.» Read More
KALAMAZOO, Mich. _ Stryker Corp. on Thursday reported net income of $57 million in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share. Analysts expected $2.33 billion, according to Zacks.
July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.
July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations on increased sales of reconstructive and surgical products. The company posted net profit of $215 million, or 56 cents per share, compared with a profit of $213 million, or 56 cents per share, a year ago.
*AbbVie raises bid to 53.20/ share from 51.15. *Bid comprises 24.44 stg cash and 0.8960 new AbbVie shares. LONDON, July 14- London- listed drugmaker Shire Plc succumbed to an increased 31 billion pounds takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax.
It's time for the Lightning Round. Cramer makes the call on viewer favorites.
NEW YORK, June 19- It's the secret fear of every American parent: failure to launch. The idea used to give Andy Byron the cold sweats. Their 22- year-old son scored a paid summer internship with medical device manufacturer Stryker Corp, with an eye toward a career in medical sales.
June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.
Some of Monday's midday movers:
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
Some of the names on the move ahead of the open.
One of the world's largest makers of medical devices, Medtronic, is considering a takeover of London-based Smith & Nephew, Bloomberg said.
Jim Cramer thinks there’s something Johnson & Johnson could do, right now, to create significant shareholder value.
More and more foreign buyers are finding the U.K.'s takeover laws difficult to navigate.
Some of Thursday's midday movers:
Some of Wednesday's midday movers:
Some of Tuesday's midday movers:
Worried about Washington's next fiscal folly? These stocks should weather the next storm, according to two top money managers.
Stryker CEO Kevin Lobo says his company is in "great shape," and discusses the gradual increase in people electing to have surgery. He also addresses the hit from recall costs.
Check out which companies are making headlines after the bell Thursday:
With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.